Chip giant Nvidia has developed a supercomputer for Danish pharma company Novo Nordisk, the maker of blockbuster weight loss ...
Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity ...
The active ingredient in Ozempic and Wegovy has once again proven to have health effects outside of weight loss in a huge ...
Critics, including Senator Bernie Sanders, question whether the push to block alternatives is truly about safety — or simply ...
Novo Nordisk is urging the U.S. Food and Drug Administration (FDA) to block ‘copycat’ versions of its popular weight-loss and ...
The full-year cost of care for U.S. patients with obesity, two years after starting on Novo Nordisk's Wegovy or similar GLP-1 ...
The University of California, Davis today announced an expanded collaboration with the BioInnovation Institute (BII) to ...
A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present ...
City employees in NYC had insurance coverage for GLP-1 drugs like Wegovy and Zepbound for less than a year before learning it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback